Cargando…
Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma
BACKGROUND & AIMS: In the USA, inequal liver transplantation (LT) access exists between patients with and without hepatocellular carcinoma (HCC). Survival benefit considers survival without and with LT and could equalise LT access. We calculated bias-corrected LT survival benefit for patients wi...
Autores principales: | Goudsmit, Ben F.J., Ilaria Prosepe, Tushuizen, Maarten E., Mazzaferro, Vincenzo, Alwayn, Ian P.J., van Hoek, Bart, Braat, Andries E., Putter, Hein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685016/ https://www.ncbi.nlm.nih.gov/pubmed/38034881 http://dx.doi.org/10.1016/j.jhepr.2023.100907 |
Ejemplares similares
-
Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure
por: Goudsmit, Ben F.J., et al.
Publicado: (2021) -
Refitting the Model for End‐Stage Liver Disease for the Eurotransplant Region
por: Goudsmit, Ben F. J., et al.
Publicado: (2021) -
Joint modeling of liver transplant candidates outperforms the model for end‐stage liver disease: The effect of disease development over time on patient outcome
por: Goudsmit, Ben F. J., et al.
Publicado: (2021) -
Validation of the Model for End‐stage Liver Disease sodium (MELD‐Na) score in the Eurotransplant region
por: Goudsmit, Ben F. J., et al.
Publicado: (2020) -
Invited response to “MELD calibration”
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)